Ferring Pharmaceuticals

ACTHREL

Manufacturer:

Ferring Pharmaceuticals

Acthrel HCPCS:

J0795

HCPCS Code Descriptor:

Injection, corticorelin ovine triflutate, 1 microgram

Category:

J Code

Acthrel NDCs:

No actively aligned NDCs found

Primary Type:

Growth Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Acthrel:

ACTHREL is a Growth Disorder drug manufactured by Ferring Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J0795 is aligned to the drug ACTHREL.

ACCESS PRICING AND MORE BY REGISTERING

J0795 Added Date:

January 1, 2006

J0795 Effective Date:

January 1, 2023

J0795 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Acthrel billing and coding information.
Our team did not identify a source for Acthrel patient assistance information. Please reach out to our team if you feel that this is a mistake.
ACTHREL prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ACTHREL. Please check back in a few weeks.